APA (7th ed.) Citation

Y, L., M, T., H, D., Y, L., J, W., L, L., . . . W, H. (2026). Defective efferocytosis in diabetes: Molecular mechanisms and emerging therapeutic strategies. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 75(1), . https://doi.org/10.1007/s00011-026-02302-w

Chicago Style (17th ed.) Citation

Y, Lei, et al. "Defective Efferocytosis in Diabetes: Molecular Mechanisms and Emerging Therapeutic Strategies." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.] 75, no. 1 (2026). https://doi.org/10.1007/s00011-026-02302-w.

MLA (9th ed.) Citation

Y, Lei, et al. "Defective Efferocytosis in Diabetes: Molecular Mechanisms and Emerging Therapeutic Strategies." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.], vol. 75, no. 1, 2026, https://doi.org/10.1007/s00011-026-02302-w.